A comprehensive view of Perrigo PLC. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Packaging for Perrigo’s Opill, the first OTC birth control pill to be sold in US, features bright teal, saturated pink and yellow, plus a rounded font reminiscent of Gotham; design is intended to set product apart from prescription contraceptive pills
Published: July 31, 2023 by STAT News
Perrigo recalls certain lots of Gerber Good Start SoothePro Powdered Infant Formula in the US because of potential cronobacter sakazakii contamination
Published: May 15, 2023 by Food Safety News
FDA panel backs OTC sales of Perrigo's Opill contraceptive pill; ruling comes despite criticisms from some FDA scientists who voiced concerns about how Perrigo studied the drug
Published: May 11, 2023 by Associated Press
FDA advisers to review first request to allow OTC sales of Perrigo's Opill birth control pill; FDA raises concerns about Opill studies and reliability of some company data
Published: May 05, 2023 by Associated Press
FDA to discuss OTC approval for Perrigo's birth control medication Opill on May 9-10; if approved, Opill would become the first daily OTC contraceptive drug available
Published: April 10, 2023 by Indian Pharma Industry : Policies

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count